Page 20 - Part D News Today

If your Medicare Part D premium will increase by a lot in 2024, you could save a lot of money by shopping your policy.

It's an important time of the year to make sure you are fully insured and there is free assistance to make sure you are fully covered. Medicare Part D Open Enrollment is currently underway. This is a plan that covers prescription drugs. "It's that time of year where we are reviewing our plans and making sure we are covered for next year," said Jon Godfread, North Dakota Insurance Commissioner. "It's really important, it's critically important to review this on ...

Medicare is for people 65 or older (and some individuals under 65 who are disabled, blind, have ALS, or End-Stage Renal Disease). If you are about to turn 65, no

Despite health officials urging Americans to get the updated COVID-19 vaccine, distribution issues have caused delays in the rollout process.

Mercy Health is hosting an educational event Oct. 2 for Medicare beneficiaries at Mercy Health - Lorain Hospital Medical Office Building, 3600 Kolbe Road in Lorain, according to a news release.

For the first time, Medicare will negotiate with drug companies to lower prices on life-saving prescriptions. These medications made the list.

Wont big pharma, if they lose the suits, stop the program? wont they just try to find the money elsewhere out of consumers? >> yeah, andrea, thats a possibility. but i think what was brilliant in terms of the way medicare is going to roll this program out is that these ten drugs will soon become 20 drugs and different drugs year after year. even if manufacturers try to do something around, lets say, the ten specific drugs, it is impossible to concede that they could do that for every single drug...

On the one-year anniversary of the IRA’s signing, most of the bill’s impact on drug prices and Medicare beneficiary out-of-pocket spending has yet to be determined.

Medicare drug price negotiations are due to start Sept. 1 with the first 10 prescriptions. But some drug companies are asking courts to postpone.

A new report found that 25 of the top brand-name prescription drugs in the Medicare Part D program are skyrocketing in price. See what made the list.